ReviewFrontiers in pharmacology2026

Genome agnostic, multi-level non-oncogene addiction-based systems pharmacology for rescuing metastatic relapsed/refractory neoplasias.

Dennis Christoph Harrer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.